Fasting blood glucose (FG), Fasting insulin (FI), and glycosylated hemoglobin (HbA1c) are significant indicators in the clinical treatment of diabetes.[22] In addition, C-reactive protein (CRP) is proved to be closely associated with the high risk of NAFLD.[23] In this study, 2 obesity-related indicators, 3 diabetes-related indicators and one inflammation-related indicator were included to investigate the association between them and NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.